Search hospitals > Alabama > Birmingham

University of Alabama at Birmingham

Claim this profile
Birmingham, Alabama 35205
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for HIV Infection
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Cystic Fibrosis
2622 reported clinical trials
273 medical researchers
Photo of University of Alabama at Birmingham in BirminghamPhoto of University of Alabama at Birmingham in Birmingham

Summary

University of Alabama at Birmingham is a medical facility located in Birmingham, Alabama. This center is recognized for care of Cancer, Breast Cancer, HIV Infection, Human Immunodeficiency Virus Infection, Cystic Fibrosis and other specialties. University of Alabama at Birmingham is involved with conducting 2,622 clinical trials across 2,240 conditions. There are 273 research doctors associated with this hospital, such as Mustafa Ahmed, MD, Girish Dhall, MD, Rebecca C. Arend, and Jonathan McConathy, MD, PhD.

Area of expertise

1Cancer
Global Leader
University of Alabama at Birmingham has run 120 trials for Cancer. Some of their research focus areas include:
Stage IV
HER2 positive
Stage III
2Breast Cancer
Global Leader
University of Alabama at Birmingham has run 118 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 positive
Stage III

Top PIs

Clinical Trials running at University of Alabama at Birmingham

Multiple Myeloma
Sickle Cell Disease
Stroke
Breast Cancer
Gout
Chronic Obstructive Pulmonary Disease
Urinary Incontinence
Cancer
Idiopathic Pulmonary Fibrosis
Premature Birth
Image of trial facility.

Iberdomide Combo

for Multiple Myeloma

Similar to the paradigm established in other hematologic malignancies that are considered curable, the achievement of MRD(-) status is necessary for long term disease control in MM. The fact that the majority of patients remain MRD (+) after induction therapy and AHCT points to the opportunity to deploy novel agents with complementary mechanism of action and favorable toxicity profile to reach and maintain MRD (-) status. Given its favorable toxicity profile, the convenience of oral administration, and compelling single agent activity even in heavily pretreated MM, iberdomide is likely amenable to long term therapy in patients with high-risk of relapse/progression identified by the persistence of MRD(+). The investigators intend to develop combination(s) of iberdomide with other agents with complementary mechanism of action in the consolidation setting post AHCT in order to achieve and sustain MRD (-).
Recruiting3 awards Phase 1 & 214 criteria
Image of trial facility.

DaraVRD

for Multiple Myeloma

This trial uses a high-tech test to check for tiny amounts of leftover cancer cells in patients with newly diagnosed multiple myeloma. If no cancer cells are found, doctors might delay a major treatment called stem cell transplant. This approach aims to avoid the severe side effects of the transplant if it's not needed.
Recruiting3 awards Phase 29 criteria
Image of trial facility.

BMS-986393

for Multiple Myeloma

The purpose of this study is to compare the efficacy and safety of arlo-cel (BMS-986393) versus standard regimens in adult participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma.
Recruiting2 awards Phase 33 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Alabama at Birmingham?
Where is University of Alabama at Birmingham located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of Alabama at Birmingham accept?
What awards or recognition has University of Alabama at Birmingham received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security